Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Comparing weight-loss surgeries and GLP-1 drugs for effectiveness: a review and analysis

Updated

Abstract

Obesity is a global health crisis associated with increased morbidity and mortality.

  • Obesity is linked to serious health issues, including type 2 diabetes and cardiovascular disease.
  • Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are gaining attention for weight loss and blood sugar management.
  • Metabolic and bariatric surgery (MBS) shows more established long-term outcomes compared to pharmacologic interventions.
  • Limited direct comparative data exists on the effectiveness of GLP-1 RAs versus MBS regarding mortality and cardiovascular health.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free